These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11683423)

  • 41. Eldecalcitol and calcitriol stimulates 'bone minimodeling,' focal bone formation without prior bone resorption, in rat trabecular bone.
    Saito H; Takeda S; Amizuka N
    J Steroid Biochem Mol Biol; 2013 Jul; 136():178-82. PubMed ID: 23069645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients.
    Kubodera N; Tsuji N; Uchiyama Y; Endo K
    J Cell Biochem; 2003 Feb; 88(2):286-9. PubMed ID: 12520528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Osteoporosis in rheumatoid arthritis--significance of alfacalcidol in prevention and therapy].
    Schacht E
    Z Rheumatol; 2000; 59 Suppl 1():10-20. PubMed ID: 10769429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new synthetic steroid, osaterone acetate (TZP-4238), increases cortical bone mass and strength by enhancing bone formation in ovariectomized rats.
    Fuse H; Fukumoto S; Sone H; Miyata Y; Saito T; Nakayama K; Takahashi H; Matsumoto T; Ogata E
    J Bone Miner Res; 1997 Apr; 12(4):590-7. PubMed ID: 9101370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of D-003, a mixture of very high molecular weight aliphatic acids, on prednisolone-induced osteoporosis in Sprague-Dawley rats.
    Noa M; Mendoza S; Más R; Mendoza N; León F
    Drugs R D; 2004; 5(5):281-90. PubMed ID: 15357627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of a combined alendronate and calcitriol agent (Maxmarvil) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study.
    Rhee Y; Kang M; Min Y; Byun D; Chung Y; Ahn C; Baek K; Mok J; Kim D; Kim D; Kim H; Kim Y; Myoung S; Kim D; Lim SK
    Osteoporos Int; 2006 Dec; 17(12):1801-7. PubMed ID: 17019520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early postmenopausal bone loss is prevented by estrogen and partially by 1alpha-OH-vitamin D3: therapeutic effects of estrogen and/or 1alpha-OH-vitamin D3.
    Gorai I; Chaki O; Taguchi Y; Nakayama M; Osada H; Suzuki N; Katagiri N; Misu Y; Minaguchi H
    Calcif Tissue Int; 1999 Jul; 65(1):16-22. PubMed ID: 10369728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in quantitative bone histomorphometry in aging healthy men.
    Clarke BL; Ebeling PR; Jones JD; Wahner HW; O'Fallon WM; Riggs BL; Fitzpatrick LA
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2264-70. PubMed ID: 8964862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol.
    Schacht E
    Calcif Tissue Int; 1999 Oct; 65(4):317-27. PubMed ID: 10485985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of alfacalcidol on mechanical properties and collagen cross-links of the femoral diaphysis in glucocorticoid-treated rats.
    Saito M; Marumo K; Ushiku C; Kato S; Sakai S; Hayakawa N; Mihara M; Shiraishi A
    Calcif Tissue Int; 2011 Apr; 88(4):314-24. PubMed ID: 21327766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of intermittent administration of human PTH on experimental osteopenia in adult rat: a histomorphometric study of both trabecular and cortical bone of the vertebrae].
    Narita Y
    Nihon Seikeigeka Gakkai Zasshi; 1995 Oct; 69(10):1027-36. PubMed ID: 8551088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat.
    Bryer HP; Isserow JA; Armstrong EC; Mann GN; Rucinski B; Buchinsky FJ; Romero DF; Epstein S
    J Bone Miner Res; 1995 Jan; 10(1):132-8. PubMed ID: 7747620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
    Exp Anim; 2006 Jul; 55(4):333-42. PubMed ID: 16880680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone.
    Liu CC; Kalu DN; Salerno E; Echon R; Hollis BW; Ray M
    J Bone Miner Res; 1991 Oct; 6(10):1071-80. PubMed ID: 1796755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The bisphosphonate 2-PEBP inhibits cyclosporin A induced high-turnover osteopenia in the rat.
    Movsowitz C; Epstein S; Fallon M; Ismail F; Thomas S
    J Lab Clin Med; 1990 Jan; 115(1):62-8. PubMed ID: 2299257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short-term prophylaxis against estrogen depletion-induced bone loss with calcitriol does not provide long-term beneficial effects on cancellous bone mass or structure in ovariectomized rats.
    Erben RG; Bromm S; Stangassinger M
    Osteoporos Int; 1998; 8(1):82-91. PubMed ID: 9692082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis.
    Verhaeghe J; van Herck E; Visser WJ; Suiker AM; Thomasset M; Einhorn TA; Faierman E; Bouillon R
    Diabetes; 1990 Apr; 39(4):477-82. PubMed ID: 2180758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of glucocorticoid on bone in 3-, 6-, and 12-month-old rats as determined by bone mass and histomorphometry.
    Ogoshi T; Hagino H; Fukata S; Tanishima S; Okano T; Teshima R
    Mod Rheumatol; 2008; 18(6):552-61. PubMed ID: 18648735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.